Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc. (BOLT) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
bolt · stock forecast · 8 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 8 Wall Street analysts in the past 3 months
Hold
8 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$7.00
Consensus
$4.00
-15.3% upside
Low
$1.00
Median: $4 · Last Close: $4.72
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$4.00
-15.3% upside
High Target
$7
48.3%
Low Target
$1
-78.8%
Current Price
$4.72
as of today
Based on analyst price targets, the BOLT stock price prediction for the next 12 months ranges from $1 to $7. The consensus BOLT price forecast of $4.00 implies -15.3% upside from the current price of $4.72.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $4.65 | ↓ 1.48% |
1-day model range: $4.56–$4.74. Peak: $4.74 (-1.48%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · BOLT · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-15 | Lake Street | Maintains | Buy→Buy |
| 2025-05-13 | Stifel | Maintains | Hold→Hold |
| 2025-03-25 | Stifel | Maintains | Hold→Hold |
| 2025-03-25 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2024-05-15 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2024-05-15 | Stifel | Downgrade ↓ | Buy→Hold |
| 2024-05-15 | Guggenheim | Downgrade ↓ | Buy→Neutral |
| 2024-05-15 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
Wall Street analysts have recently issued updated ratings on Bolt Biotherapeutics, Inc. (BOLT) stock. Of the recent 30 rating actions, 1 were upgrades and 7 were downgrades. 8 analysts currently cover BOLT.
Analyst Recommendation Trends
BOLT analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1M
↓ 71.7% YoY
Revenue Next Year
$2M
↑ 106.2% YoY
EPS This Year
$-15.88
EPS Next Year
$-19.93
↑ 25.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast BOLT EPS of $-15.88 for the current fiscal year, based on estimates from 2 analysts. The BOLT revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BOLT stock forecast is supported by two independent data sources: analyst consensus ratings from 8 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BOLT price target is $4.00 (-15.3% upside), with an analyst consensus of Hold.
The BOLT short-term stock prediction for tomorrow is $4.65 (-1.48%). The BOLT stock prediction for 2030 projects a range of $1–$2.
Bolt Biotherapeutics, Inc. trades on NASDAQ under the ticker BOLT. The BOLT stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 38% of covering analysts.
Frequently asked questions
BOLT forecast · 8 questionsAccording to 8 Wall Street analysts, the average 12-month BOLT price target is $4.00, with a high forecast of $7.00 and a low of $1.00. The median price target is shown in the chart above when available. This implies -15.3% potential upside from the current price of $4.72.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.